FALCHETTI, ALBERTO
FALCHETTI, ALBERTO
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
2012 A. Falchetti; A. Gozzini; A. Terranegra; L. Soldati; G. Vezzoli; G. Leoncini; F. Giusti; F. Franceschelli; L. Masi; A. Tanini; L. Cavalli; M.L. Brandi
A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis
2009 L.Masi; A.Gozzini; A.Franchi; D.Campanacci; A.Amedei; A.Falchetti; F.Franceschelli; G.Marcucci; A.Tanini; R.Capanna; M.L.Brandi
A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
2008 A Falchetti; A Cilotti; L Vaggelli; L Masi; A Amedei; F Cioppi; F Tonelli; M L Brandi
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.
2004 L. GENNARI; L. MASI; L. PICARIELLO; A. FALCHETTI; A. TANINI; C. MAVILIA; F. DEL MONTE; S. GONNELLI; M.L. BRANDI; D. MERLOTTI; B. LUCANI; C. GENNAI
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
1997 C. Bordi; A. Falchetti; C. Azzoni; T. D'Adda; G. Canavese; A. Guariglia; D. Santini; P. Tomassetti; M. L. Brandi
ALLELIC LOSS AT THE VITAMIN D RECEPTOR (VDR) LOCUS IN PARATHYROID TISSUE FROM ONE PATIENT AFFECTED BY REFRACTORY UREMIC HYPERPARATTHYROIDISM
2005 A. FALCHETTI; A. GOZZINI; L. MASI; V. MARTINETI; S. BANDINI; M.L. BRANDI
Allelic loss in parathyroid tumors from individualshomozygous for multiple endocrine neoplasia type 1.
1997 Falchetti A; Morelli A; Amorosi A; Tonelli F; Fabiani S; Martineti V; Castello R; Furlani L; Brandi ML.
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women
1998 MASI L.; BECHERINI L.; GENNARI L.; COLLI E.; MANSANI R.; FALCHETTI A.; CEPOLLARO C.; GONNELLI S.; TANINI A.; M. BRANDI
Analysis of estrogen receptor (ERalpha and ERbeta and progesterone receptor (PR) polymorphisms in uterine leiomyomas.
2003 F. MASSART; L. BECHERINI; F. MARINI; I. NOCI; L. PICIOCCHI; F. DEL MONTE; L. MASI; A. FALCHETTI; A. TANINI; G. SCARSELLI; BRANDI M.L.
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy sindrome (APECED): report on three cases from Southern Italy.
2004 DE FEO M.L; SERIO M; LADU C; FALCHETTI A; MASI L; GOZZINI A; MARINI F; A. TANINI; BRANDI M.L.
AZIDOTHYMIDINE INDUCES APOPTOSIS AND INHIBITS CELL GROWTH AND TELOMERASE ACTIVITY OF HUMAN PARATHYROID CANCER IN CELL CULTURE
2005 A. TANINI; C. MAVILIA; M. BRANDI; L. PICARIELLO; A. FRANCHI; R. RECENTI; F. DEL MONTE; A. FALCHETTI; V. MARTINETI; F. MARINI; F. CIOPPI; C. BORDI; V. GHINOI
Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women
2009 Cavalli, Loredana; Cavalli, Tiziana; Marcucci, Gemma; Falchetti, Alberto; Masi, Laura; Brandi, Maria Luisa
Calcium bioavailability from a calcium-rich mineral water, with some observations on method.
2004 L. BACCIOTTINI; A. TANINI; A. FALCHETTI; L. MASI; F. FRANCESCHELLI; B. PAMPALONI; G. GIORGI; M.L. BRANDI
Characterisation of a Non-UBA Domain Missense Mutation of Sequestosome 1 (SQSTM1) in Paget's Disease of Bone.
2008 D. Najat; T. Garner; T. Hagen; B. Shaw; Paul W Sheppard; A. Falchetti; F. Marini; M. L. Brandi; J. E Long; J. R Cavey; Mark S Searle; R. Layfield
Characterization and function of the receptor for IGF-I in human preosteoclastic cells.
1996 G. Fiorelli; L. Formigli; S. Zecchi Orlandini; F. Gori; A. Falchetti; A. Morelli; A. Tanini; S. Benvenuti; M. L. Brandi
Clonal analysis by chromosome 11 microsatellite-PCR ofmicrodissected parathyroid tumors from MEN 1 patients.
1996 Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML.
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.
1989 E. Friedman; K. Sakaguchi; A. E. Bale; A. Falchetti; E. Streeten; M. B. Zimering; L. S. Weinstein; W. O. McBride; Y. Nakamura; M. L. Brandi
CONSENSUS STATEMENT ON DIAGNOSIS OF PRIMARY HYPERCALCIURIA
2004 E. CROPPI; A. FALCHETTI; G. VEZZOLI; M.L. BRANDI; BEVILACQUA; L. BORGHI; R. CAUDARELLA; G. GAMBARO; M. MARANGELLA; A. TRINCHIERI
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.
2011 F. Giusti;S. Ottanelli;L. Masi;A. Amedei;M. L. Brandi;A. Falchetti
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes
2009 A.Falchetti; F.Marini; F.Giusti; L.Cavalli; T.Cavalli; M.L.Brandi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. | 2012 | A. Falchetti; A. Gozzini; A. Terranegra; L. Soldati; G. Vezzoli; G. Leoncini; F. Giusti; F. Franceschelli; L. Masi; A. Tanini; L. Cavalli; M.L. Brandi | |
| A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis | 2009 | L.Masi; A.Gozzini; A.Franchi; D.Campanacci; A.Amedei; A.Falchetti; F.Franceschelli; G.Marcucci; A.Tanini; R.Capanna; M.L.Brandi | |
| A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. | 2008 | A Falchetti; A Cilotti; L Vaggelli; L Masi; A Amedei; F Cioppi; F Tonelli; M L Brandi | |
| A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. | 2004 | L. GENNARI; L. MASI; L. PICARIELLO; A. FALCHETTI; A. TANINI; C. MAVILIA; F. DEL MONTE; S. GONNELLI; M.L. BRANDI; D. MERLOTTI; B. LUCANI; C. GENNAI | |
| Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. | 1997 | C. Bordi; A. Falchetti; C. Azzoni; T. D'Adda; G. Canavese; A. Guariglia; D. Santini; P. Tomassetti; M. L. Brandi | |
| ALLELIC LOSS AT THE VITAMIN D RECEPTOR (VDR) LOCUS IN PARATHYROID TISSUE FROM ONE PATIENT AFFECTED BY REFRACTORY UREMIC HYPERPARATTHYROIDISM | 2005 | A. FALCHETTI; A. GOZZINI; L. MASI; V. MARTINETI; S. BANDINI; M.L. BRANDI | |
| Allelic loss in parathyroid tumors from individualshomozygous for multiple endocrine neoplasia type 1. | 1997 | Falchetti A; Morelli A; Amorosi A; Tonelli F; Fabiani S; Martineti V; Castello R; Furlani L; Brandi ML. | |
| Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women | 1998 | MASI L.; BECHERINI L.; GENNARI L.; COLLI E.; MANSANI R.; FALCHETTI A.; CEPOLLARO C.; GONNELLI S.; TANINI A.; M. BRANDI | |
| Analysis of estrogen receptor (ERalpha and ERbeta and progesterone receptor (PR) polymorphisms in uterine leiomyomas. | 2003 | F. MASSART; L. BECHERINI; F. MARINI; I. NOCI; L. PICIOCCHI; F. DEL MONTE; L. MASI; A. FALCHETTI; A. TANINI; G. SCARSELLI; BRANDI M.L. | |
| Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy sindrome (APECED): report on three cases from Southern Italy. | 2004 | DE FEO M.L; SERIO M; LADU C; FALCHETTI A; MASI L; GOZZINI A; MARINI F; A. TANINI; BRANDI M.L. | |
| AZIDOTHYMIDINE INDUCES APOPTOSIS AND INHIBITS CELL GROWTH AND TELOMERASE ACTIVITY OF HUMAN PARATHYROID CANCER IN CELL CULTURE | 2005 | A. TANINI; C. MAVILIA; M. BRANDI; L. PICARIELLO; A. FRANCHI; R. RECENTI; F. DEL MONTE; A. FALCHETTI; V. MARTINETI; F. MARINI; F. CIOPPI; C. BORDI; V. GHINOI | |
| Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women | 2009 | Cavalli, Loredana; Cavalli, Tiziana; Marcucci, Gemma; Falchetti, Alberto; Masi, Laura; Brandi, Maria Luisa | |
| Calcium bioavailability from a calcium-rich mineral water, with some observations on method. | 2004 | L. BACCIOTTINI; A. TANINI; A. FALCHETTI; L. MASI; F. FRANCESCHELLI; B. PAMPALONI; G. GIORGI; M.L. BRANDI | |
| Characterisation of a Non-UBA Domain Missense Mutation of Sequestosome 1 (SQSTM1) in Paget's Disease of Bone. | 2008 | D. Najat; T. Garner; T. Hagen; B. Shaw; Paul W Sheppard; A. Falchetti; F. Marini; M. L. Brandi; J. E Long; J. R Cavey; Mark S Searle; R. Layfield | |
| Characterization and function of the receptor for IGF-I in human preosteoclastic cells. | 1996 | G. Fiorelli; L. Formigli; S. Zecchi Orlandini; F. Gori; A. Falchetti; A. Morelli; A. Tanini; S. Benvenuti; M. L. Brandi | |
| Clonal analysis by chromosome 11 microsatellite-PCR ofmicrodissected parathyroid tumors from MEN 1 patients. | 1996 | Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML. | |
| Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. | 1989 | E. Friedman; K. Sakaguchi; A. E. Bale; A. Falchetti; E. Streeten; M. B. Zimering; L. S. Weinstein; W. O. McBride; Y. Nakamura; M. L. Brandi | |
| CONSENSUS STATEMENT ON DIAGNOSIS OF PRIMARY HYPERCALCIURIA | 2004 | E. CROPPI; A. FALCHETTI; G. VEZZOLI; M.L. BRANDI; BEVILACQUA; L. BORGHI; R. CAUDARELLA; G. GAMBARO; M. MARANGELLA; A. TRINCHIERI | |
| Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors. | 2011 | F. Giusti;S. Ottanelli;L. Masi;A. Amedei;M. L. Brandi;A. Falchetti | |
| DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes | 2009 | A.Falchetti; F.Marini; F.Giusti; L.Cavalli; T.Cavalli; M.L.Brandi |